MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1Wu Huijuan, Quan Hao, Ke Wang et al.|Biochemical and Biophysical Research Communications|2013Cited by 84
MiR-489 modulates cisplatin resistance in human ovarian cancer cells by targeting Akt3Wu Huijuan, Quan Hao, Zhenghua Xiao et al.|Anti-Cancer Drugs|2014Cited by 53